for such a case, you need to have some fundamental news about the company.
Then take a position before the breakout ( medicine approval process).
Such a chart is very typical of pharmaceutical companies.
of course, if the approval process is negative, there wouldn't be any breakout.
Services out there such as BiopharmIQ or something like that provide upcoming catalyst for health technology tickers. But most if them fail to pass the FDA approval. Gap down most likely.